Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study
Introduction This protocol is describing a multicentre, single-blind randomised controlled trial. The objective is to compare the efficacy of MyndMove therapy versus conventional therapy (CT) in improving upper extremity function in individuals with C4–C7 traumatic, incomplete spinal cord injury (SC...
Saved in:
| Main Authors: | Lehana Thabane, Milos R Popovic, Kristin E Musselman, Daria O'Reilly, James M Bowen, Kim D Anderson, James R Wilson, Radha Korupolu, Jacqueline Pierce, Naaz Kapadia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e039650.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MyndFood: a conversational agent for enhancing the cooking and eating experience
by: Mario O. Parra, et al.
Published: (2025-04-01) -
Ultrasound Neuromodulation as a New Brain Therapy
by: Roland Beisteiner, et al.
Published: (2023-05-01) -
Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression
by: Andrew D. Geoly, et al.
Published: (2025-05-01) -
An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
by: Katy H. Stimpson, et al.
Published: (2025-07-01) -
Advancing Neuroscience and Therapy: Insights into Genetic and Non-Genetic Neuromodulation Approaches
by: Weijia Zhi, et al.
Published: (2025-01-01)